SlideShare a Scribd company logo
1 of 54
Download to read offline
EVALUATION & TREATMENT OF OVER- AND
UNDER-METHYLATION IN THE PSYCHIATRIC
POPULATION
William J. Walsh, PhD
Walsh Research Institute
February 18, 2015
1
Webinar Topics
1. Methylation
2. Epigenetics
3. Treatment of psychiatric patients who
exhibit a methylation disorder.
2
Walsh Research Institute
Naperville, Illinois
 501c3 Public Charity
 Expertise in behavior disorders, ADHD,
autism, depression, schizophrenia,
bipolar disorder, and Alzheimer’s
 International Physician-Training Program
 Research
3
Massive Chemistry Database
 Laboratory testing of 30,000 mental health
patients and controls.
 More than 3 million chemical test results for
patients diagnosed with schizophrenia,
depression, ADHD, depression, autism, etc.
 More than 2 million medical history factors
for these populations.
4
Database Findings
Striking blood/urine chemistry
differences between mental illness
populations and the rest of society.
Walsh WJ (2012). Nutrient Power. Skyhorse Publishing, New York, NY.
Crayton JW, Walsh WJ (2007). J Trace Elements Med Biol.21:17-21.
5
High-Incidence Imbalances in
Mental Disorders
Methylation Disorder
Zinc Deficiency
Copper Overload
Folate Deficiency or Overload
Pyrrole Disorder
Toxic-Metal Overload
EPA, DHA, and/or AA Deficiency
These factors have a powerful impact on synthesis of
neurotransmitters and regulation of NT activity.
6
Methylation and Brain Disorders
 Methylation status has been determined for
30,000 patients over a 30 year period,
 Most persons diagnosed with mental
disorders exhibit a serious methylation
imbalance,
 Accurate diagnosis of methylation status is
essential to effective treatment.
7
Recent Advances in
Understanding of Brain Disorders
Methylation Processes
Epigenetics
8
New Capability in Nutrient Therapy
 Regulation of enzyme gene expression,
 Control of serotonin & dopamine reuptake,
 Improved antioxidant protection in the brain,
 Promising treatments for addiction disorders.
9
“I did then what I knew how to do.
Now that I know better, I do better.”
Maya Angelou
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Single Nucleotide Polymorphisms
 We share 99.9% of our DNA with everyone of
the same gender -- It’s the 0.1% that makes
us different.
 SNPs are gene mutations that developed
over thousands of years.
 More than 10 million SNPs have been
identified in the human genome. Most
humans have more than 1,000 SNPs.
28
ENZYME SNPs
 More likely in very-large enzymes,
 Most SNPs have little or no effect on enzyme
function,
 Some strategically-placed SNPs significantly
weaken enzyme function (MTHFR 677T, etc.),
 Impact of a SNP varies from person to
person.
29
Size Matters
 MTHFR – more than 500 amino acids, MW
77,000; 677T SNP present in >20% of all
humans; 52% of all Italians.
 Metallothionein – 61 amino acids – SNPs
far less common but generally more
harmful with respect to function.
30
Methylation and Epigenetics
 Methylation is a dominant factor in epigenetic
processes,
 SAMe, folates, niacin, and other nutrients have a
powerful epigenetic impact on neurotransmitter
activity at synapses,
 More than 60% of ADHD, anxiety, depression and
psychosis patients exhibit a serious methylation
imbalance.
31
Epigenetics
 >20,000 genes in every cell’s DNA, each capable of
producing a specific protein,
 Liver, skin, brain, and other tissues require a unique
combination of proteins,
 During pregnancy, chemical “bookmarks” attach to
DNA to enhance or inhibit gene expression in each
tissue,
 Environmental insults at any age can alter gene
bookmarks and produce mental disorders and other
disease conditions.
32
Two Epigenetic Processes
DNA Methylation
Histone Modification
33
DNA Methylation
 Established in the womb,
 Methylation of cytosine at promoter CpG island clusters
can reduce expression (protein production) for the
corresponding gene. These methyl “bookmarks” usually
remain in place throughout a lifetime,
 In-utero environmental insults can produce deviant
bookmarks & serious disorders or birth defects,
 Throughout life, a severe environmental insult may alter
one or more gene-regulation marks and produce an
epigenetic disorder such as cancer or a mental illness.
34
DNA Methylation35
Histones – Support Structures
for the Fragile DNA
 Composed of 8 linear proteins twisted together like a ball
of yarn,
 Originally believed to serve only as structural support for
DNA packaging,
 Later found to inhibit or promote gene expression
depending on chemical reactions at histone tails.
 Nutrient therapies can modify histones that control
reuptake of serotonin, dopamine, and other NTs.
36
37
38
Methyl-Acetyl Competition
 Competition between acetyl and methyl groups often
determines whether genes are expressed or silenced,
 Acetyl bookmarks promote gene expression,
 Methyl bookmarks inhibit expression,
 Nutrient therapy can change methyl/acetyl ratios and
adjust production of enzymes that control serotonin
and dopamine neurotransmission rates.
39
Gene Expression
Requires Uncoiling of DNA
 Gene expression involves direct interaction of RNA
polymerase and transcription factors with DNA. These
large molecules cannot gain access to DNA/histone
regions that are densely compacted,
 The gentle attachment of DNA to histones involves
electrostatic attraction – DNA is a weak acid and
histones are mild bases (pH above 7.0),
 Acetylation decreases histone pH, causing uncoiling
of DNA; methylation increases histone pH, increasing
DNA/Histone compaction.
40
41
42
Reuptake Transport Proteins
 Primary determinant of neurotransmitter activity at
serotonin & dopamine receptors – brain concentrations
of serotonin and dopamine are less important,
 Transmembrane proteins that remove neurotransmitters
from the synapse (reuptake) like a vacuum cleaner
inhaling dust particles,
 Formed by gene expression: amount present depends
on methyl/acetyl competition at specific DNA regions.
43
Enzymes Dominate the
Methyl-Acetyl Competition
 Acetyl-Coenzyme A and SAMe are the donors of acetyl
and methyl, respectively – but their concentrations in
brain cells are relatively unimportant.
 Acetylases, deacetylases, methylases and demethylases
dominate attachment or removal of acetyl or methyl
groups.
 Epigenetic nutrient therapy for adjustment of serotonin or
dopamine activity concentrates on the enzymes.
 Example: B-3 inactivates a major deacetylase inhibitor,
increasing expression of SERT, DAT transporters and
reducing serotonin and dopamine neurotransmission.
44
Epigenetic Insights Into
Nutrient Therapy
 Niacin & niacinamide act as dopamine reuptake
promoters,
 Methionine and SAMe are serotonin reuptake
inhibitors,
 Folates reduce synaptic activity at serotonin,
dopamine, and norepinephrine receptors,
 Zinc and glutathione increase glutamate activity
at NMDA receptors,
 Many nutrients influence neurotransmitter
activity and brain function.
45
Folates Reduce NT Activity
 Folic Acid, folinic acid, and L-methylfolate are
effective methylating agents.
 However, folates also increase gene expression
of SERT transport proteins, resulting in reduced
serotonin neurotransmission.
 Most undermethylated depressives with low-
serotonin activity are intolerant to folates.
46
Low Serotonin Activity
Nutrient Therapy Approach
 Enhance methylation and suppress acetylation of
DNA and histones,
 SAMe and methionine act as serotonin reuptake
inhibitors – reduced gene expression of SERT,
 Avoidance of folate supplements,
 Augmenting nutrients – zinc, serine, inositol, TMG,
Cal/Mag, Vitamins A, B-6, C, D, E.
47
Treatment Example (160 lb adult)
Undermethylated Depression
 SAMe, 400 mg/day (reduce SERT expression and
inhibit serotonin reuptake)
 B-6, 200 mg/day and P5P, 50 mg/day (enhance
synthesis of serotonin and glutathione)
Antioxidant Support
Vitamin C, 2000 mg/day
Vitamin E, 400 mg/day
Zinc (chelated form), 50 mg/day
Selenium, 100 mcg/day
Augmenting Nutrients as indicated
Biotin, Ca, Mg, Cr, TMG, Inositol, Serine, Vitamins A, D
48
Excessive Dopamine Activity
Nutrient Therapy Approach
 Support acetylation of histones with folic acid and
niacinamide (powerful deacetylase inhibitors).
 Augmenting nutrients DMAE, zinc, selenium, chromium,
Vitamins B-6, B-12, C, D, E.
 Especially promising for paranoid schizophrenics with
excessive dopamine activity.
49
Treatment Example (160 lb adult)
Excessive Dopamine Activity
 Folic Acid, 2400 mcg/day, and Niacinamide, 1000
mg/day to support acetylation of histones and
promote reuptake of dopamine.
 Augmenting nutrients DMAE, zinc, manganese,
selenium, chromium, Vitamins B-6, B-12, C, D, E.
 Especially promising for paranoid schizophrenics
and anxiety/depression patients with excessive
dopamine activity.
50
The Power of Nutrients
1. Neurotransmitter synthesis
2. Epigenetic regulation of gene
expression
3. Reuptake processes at synapses
4. Antioxidant protection
51
Summary
 Methylation imbalances play a critical role
in most mental disorders,
 Recent research in methylation and
epigenetics is providing a roadmap for
advanced nutrient therapies.
 Nutrient therapy represents an effective
weapon in the arsenal of a mental health
practitioner.
52
THANK YOU!
William J. Walsh, PhD
Walsh Research Institute
www.walshinstitute.org
53
Additional Information Sources
Nutrient Power, Chapters 3-8
www.walshinstitute.org
Physician Education Workshop
Chicago Area ● May 27-30, 2015
Contact: sue@walshinstitute.org
54

More Related Content

What's hot

Symbiotic Mind & Body
Symbiotic Mind & BodySymbiotic Mind & Body
Symbiotic Mind & Bodyparmoni
 
Jeunesse Finiti Product Sheet
Jeunesse Finiti Product SheetJeunesse Finiti Product Sheet
Jeunesse Finiti Product SheetNigel Mark Dias
 
Cyp2c9 drug metabolism
Cyp2c9 drug metabolismCyp2c9 drug metabolism
Cyp2c9 drug metabolismHanaali Ali
 
Therapeutic approaches to Protein Misfolding Diseases
Therapeutic approaches to Protein Misfolding DiseasesTherapeutic approaches to Protein Misfolding Diseases
Therapeutic approaches to Protein Misfolding DiseasesAsra Nasir Khan
 
CVA Biology I - B10vrv4133
CVA Biology I - B10vrv4133CVA Biology I - B10vrv4133
CVA Biology I - B10vrv4133ClayVirtual
 
Simple and complex protein. s2021 (2)
Simple and complex protein. s2021 (2)Simple and complex protein. s2021 (2)
Simple and complex protein. s2021 (2)Mahiraamirova1
 
Pharmacotherapies for neurodegenerative disorders
Pharmacotherapies for neurodegenerative disordersPharmacotherapies for neurodegenerative disorders
Pharmacotherapies for neurodegenerative disordersBrian Piper
 
Protein structure and disease
Protein structure and diseaseProtein structure and disease
Protein structure and diseaseamalreffat
 
The Pharmacological Intervention in Drug and Alcohol Addiction
The Pharmacological Intervention in Drug and Alcohol AddictionThe Pharmacological Intervention in Drug and Alcohol Addiction
The Pharmacological Intervention in Drug and Alcohol AddictionColleen Farrelly
 
The Neurobiology of Addiction
The Neurobiology of AddictionThe Neurobiology of Addiction
The Neurobiology of AddictionColleen Farrelly
 
Mitochondrial Disease and Toxins
Mitochondrial Disease and ToxinsMitochondrial Disease and Toxins
Mitochondrial Disease and Toxinsmitoaction
 

What's hot (16)

Phytochemicals and their effect on fetal epigenetics
Phytochemicals and their effect on fetal epigeneticsPhytochemicals and their effect on fetal epigenetics
Phytochemicals and their effect on fetal epigenetics
 
Symbiotic Mind & Body
Symbiotic Mind & BodySymbiotic Mind & Body
Symbiotic Mind & Body
 
Jeunesse Finiti Product Sheet
Jeunesse Finiti Product SheetJeunesse Finiti Product Sheet
Jeunesse Finiti Product Sheet
 
Cyp2c9 drug metabolism
Cyp2c9 drug metabolismCyp2c9 drug metabolism
Cyp2c9 drug metabolism
 
Therapeutic approaches to Protein Misfolding Diseases
Therapeutic approaches to Protein Misfolding DiseasesTherapeutic approaches to Protein Misfolding Diseases
Therapeutic approaches to Protein Misfolding Diseases
 
CVA Biology I - B10vrv4133
CVA Biology I - B10vrv4133CVA Biology I - B10vrv4133
CVA Biology I - B10vrv4133
 
Simple and complex protein. s2021 (2)
Simple and complex protein. s2021 (2)Simple and complex protein. s2021 (2)
Simple and complex protein. s2021 (2)
 
Pharmacotherapies for neurodegenerative disorders
Pharmacotherapies for neurodegenerative disordersPharmacotherapies for neurodegenerative disorders
Pharmacotherapies for neurodegenerative disorders
 
Neuropsychopharmacology
NeuropsychopharmacologyNeuropsychopharmacology
Neuropsychopharmacology
 
Protein structure and disease
Protein structure and diseaseProtein structure and disease
Protein structure and disease
 
The Pharmacological Intervention in Drug and Alcohol Addiction
The Pharmacological Intervention in Drug and Alcohol AddictionThe Pharmacological Intervention in Drug and Alcohol Addiction
The Pharmacological Intervention in Drug and Alcohol Addiction
 
Host Modulation
Host ModulationHost Modulation
Host Modulation
 
protein stability
protein stabilityprotein stability
protein stability
 
Tolcapone
TolcaponeTolcapone
Tolcapone
 
The Neurobiology of Addiction
The Neurobiology of AddictionThe Neurobiology of Addiction
The Neurobiology of Addiction
 
Mitochondrial Disease and Toxins
Mitochondrial Disease and ToxinsMitochondrial Disease and Toxins
Mitochondrial Disease and Toxins
 

Viewers also liked

New Strategy to detect SNPs
New Strategy to detect SNPsNew Strategy to detect SNPs
New Strategy to detect SNPsMiguel Galves
 
AFMS Alimenti per fini medici speciali - Quadro regolatorio e situazione attu...
AFMS Alimenti per fini medici speciali - Quadro regolatorio e situazione attu...AFMS Alimenti per fini medici speciali - Quadro regolatorio e situazione attu...
AFMS Alimenti per fini medici speciali - Quadro regolatorio e situazione attu...Maurizio Salamone
 
ECOSISTEMA INTESTINALE, CEFALEE ED EMICRANIA
ECOSISTEMA INTESTINALE, CEFALEE ED EMICRANIAECOSISTEMA INTESTINALE, CEFALEE ED EMICRANIA
ECOSISTEMA INTESTINALE, CEFALEE ED EMICRANIAMaurizio Salamone
 
Genotyping by Sequencing
Genotyping by SequencingGenotyping by Sequencing
Genotyping by SequencingSenthil Natesan
 
METHYLATION CYCLE AND IT\'S POLYMORPHISM
METHYLATION CYCLE AND IT\'S POLYMORPHISMMETHYLATION CYCLE AND IT\'S POLYMORPHISM
METHYLATION CYCLE AND IT\'S POLYMORPHISMbdiconza33
 
Single Nucleotide Polymorphism Analysis (SNPs)
Single Nucleotide Polymorphism Analysis (SNPs)Single Nucleotide Polymorphism Analysis (SNPs)
Single Nucleotide Polymorphism Analysis (SNPs)Data Science Thailand
 
Single nucleotide polymorphisms (sn ps), haplotypes,
Single nucleotide polymorphisms (sn ps), haplotypes,Single nucleotide polymorphisms (sn ps), haplotypes,
Single nucleotide polymorphisms (sn ps), haplotypes,Karan Veer Singh
 
L methylfolate The New face of Folic Acid
L methylfolate The New face of Folic AcidL methylfolate The New face of Folic Acid
L methylfolate The New face of Folic AcidGul Nawaz
 
Single nucleotide polymorphism
Single nucleotide polymorphismSingle nucleotide polymorphism
Single nucleotide polymorphismBipul Das
 

Viewers also liked (17)

7 0
7 07 0
7 0
 
New Strategy to detect SNPs
New Strategy to detect SNPsNew Strategy to detect SNPs
New Strategy to detect SNPs
 
Genome wide association mapping
Genome wide association mappingGenome wide association mapping
Genome wide association mapping
 
SNP
SNPSNP
SNP
 
AFMS Alimenti per fini medici speciali - Quadro regolatorio e situazione attu...
AFMS Alimenti per fini medici speciali - Quadro regolatorio e situazione attu...AFMS Alimenti per fini medici speciali - Quadro regolatorio e situazione attu...
AFMS Alimenti per fini medici speciali - Quadro regolatorio e situazione attu...
 
ECOSISTEMA INTESTINALE, CEFALEE ED EMICRANIA
ECOSISTEMA INTESTINALE, CEFALEE ED EMICRANIAECOSISTEMA INTESTINALE, CEFALEE ED EMICRANIA
ECOSISTEMA INTESTINALE, CEFALEE ED EMICRANIA
 
Genotyping by Sequencing
Genotyping by SequencingGenotyping by Sequencing
Genotyping by Sequencing
 
SNP Genotyping Technologies
SNP Genotyping TechnologiesSNP Genotyping Technologies
SNP Genotyping Technologies
 
METHYLATION CYCLE AND IT\'S POLYMORPHISM
METHYLATION CYCLE AND IT\'S POLYMORPHISMMETHYLATION CYCLE AND IT\'S POLYMORPHISM
METHYLATION CYCLE AND IT\'S POLYMORPHISM
 
Single Nucleotide Polymorphism Analysis (SNPs)
Single Nucleotide Polymorphism Analysis (SNPs)Single Nucleotide Polymorphism Analysis (SNPs)
Single Nucleotide Polymorphism Analysis (SNPs)
 
Single nucleotide polymorphisms (sn ps), haplotypes,
Single nucleotide polymorphisms (sn ps), haplotypes,Single nucleotide polymorphisms (sn ps), haplotypes,
Single nucleotide polymorphisms (sn ps), haplotypes,
 
SNP
SNPSNP
SNP
 
L methylfolate The New face of Folic Acid
L methylfolate The New face of Folic AcidL methylfolate The New face of Folic Acid
L methylfolate The New face of Folic Acid
 
Genetic polymorphism
Genetic polymorphismGenetic polymorphism
Genetic polymorphism
 
Snp
SnpSnp
Snp
 
Polymorphism
PolymorphismPolymorphism
Polymorphism
 
Single nucleotide polymorphism
Single nucleotide polymorphismSingle nucleotide polymorphism
Single nucleotide polymorphism
 

Similar to Methylation & Epigenetics in Psychiatric Disorders

Understanding Methylation, Gene Regulation and the MethylDetox Profile
Understanding Methylation, Gene Regulation and the MethylDetox ProfileUnderstanding Methylation, Gene Regulation and the MethylDetox Profile
Understanding Methylation, Gene Regulation and the MethylDetox ProfileCell Science Systems
 
INTRODUCTION TO NUTRIGENETICS- GENES AND ITS FUNCTIONS
INTRODUCTION TO NUTRIGENETICS- GENES AND ITS FUNCTIONSINTRODUCTION TO NUTRIGENETICS- GENES AND ITS FUNCTIONS
INTRODUCTION TO NUTRIGENETICS- GENES AND ITS FUNCTIONSAgilandeswariAT
 
New treatment trends in alzheimer disease
New treatment trends in alzheimer diseaseNew treatment trends in alzheimer disease
New treatment trends in alzheimer diseaseSarath Menon
 
Epigenetic
EpigeneticEpigenetic
EpigeneticSmawi GH
 
Epigenetics and The Molecular Mechanisms
Epigenetics and The Molecular MechanismsEpigenetics and The Molecular Mechanisms
Epigenetics and The Molecular MechanismsMUHAMMAD TUFAIL
 
Epigenetics
EpigeneticsEpigenetics
Epigeneticsgiumtell
 
Anti alzheimer drugs
Anti alzheimer drugsAnti alzheimer drugs
Anti alzheimer drugsRucha Tiwari
 
Systems and mechanisms that disrupt or deplete….dna-rna nutrient cofactors ...
  Systems and mechanisms that disrupt or deplete….dna-rna nutrient cofactors ...  Systems and mechanisms that disrupt or deplete….dna-rna nutrient cofactors ...
Systems and mechanisms that disrupt or deplete….dna-rna nutrient cofactors ...Robert Hardt
 
Nutrition Beyond Calories & the Role Trees can play
Nutrition Beyond Calories & the Role Trees can playNutrition Beyond Calories & the Role Trees can play
Nutrition Beyond Calories & the Role Trees can playWorld Agroforestry (ICRAF)
 
Dr o'flaherty nutrient therapy as complementary treatment in psychiatry
Dr o'flaherty nutrient therapy as complementary treatment in psychiatryDr o'flaherty nutrient therapy as complementary treatment in psychiatry
Dr o'flaherty nutrient therapy as complementary treatment in psychiatryInvestnet
 
Epigenetics and it's relevance in crop improvement
Epigenetics and it's relevance in crop improvementEpigenetics and it's relevance in crop improvement
Epigenetics and it's relevance in crop improvementShamlyGupta
 
Pharmacogenetics of antipsychotic and antidepressent
Pharmacogenetics of antipsychotic and antidepressentPharmacogenetics of antipsychotic and antidepressent
Pharmacogenetics of antipsychotic and antidepressentismail sadek
 
RECENT ADVANCES IN ALZHEIMER'S DISEASE
RECENT ADVANCES IN ALZHEIMER'S DISEASERECENT ADVANCES IN ALZHEIMER'S DISEASE
RECENT ADVANCES IN ALZHEIMER'S DISEASEsharad patange
 
Gut microbiota
Gut microbiotaGut microbiota
Gut microbiotaSaurav Das
 
Spirulina and human health
Spirulina and human healthSpirulina and human health
Spirulina and human healthkk321956
 

Similar to Methylation & Epigenetics in Psychiatric Disorders (20)

Understanding Methylation, Gene Regulation and the MethylDetox Profile
Understanding Methylation, Gene Regulation and the MethylDetox ProfileUnderstanding Methylation, Gene Regulation and the MethylDetox Profile
Understanding Methylation, Gene Regulation and the MethylDetox Profile
 
Exploring the MethylDetox Profile
Exploring the MethylDetox ProfileExploring the MethylDetox Profile
Exploring the MethylDetox Profile
 
Nutritional strategies for cognitive decline
Nutritional strategies for cognitive decline Nutritional strategies for cognitive decline
Nutritional strategies for cognitive decline
 
INTRODUCTION TO NUTRIGENETICS- GENES AND ITS FUNCTIONS
INTRODUCTION TO NUTRIGENETICS- GENES AND ITS FUNCTIONSINTRODUCTION TO NUTRIGENETICS- GENES AND ITS FUNCTIONS
INTRODUCTION TO NUTRIGENETICS- GENES AND ITS FUNCTIONS
 
New treatment trends in alzheimer disease
New treatment trends in alzheimer diseaseNew treatment trends in alzheimer disease
New treatment trends in alzheimer disease
 
Epigenetic
EpigeneticEpigenetic
Epigenetic
 
Epigenetics and The Molecular Mechanisms
Epigenetics and The Molecular MechanismsEpigenetics and The Molecular Mechanisms
Epigenetics and The Molecular Mechanisms
 
Epigenetics
EpigeneticsEpigenetics
Epigenetics
 
Epigenetics
Epigenetics Epigenetics
Epigenetics
 
Anti alzheimer drugs
Anti alzheimer drugsAnti alzheimer drugs
Anti alzheimer drugs
 
Systems and mechanisms that disrupt or deplete….dna-rna nutrient cofactors ...
  Systems and mechanisms that disrupt or deplete….dna-rna nutrient cofactors ...  Systems and mechanisms that disrupt or deplete….dna-rna nutrient cofactors ...
Systems and mechanisms that disrupt or deplete….dna-rna nutrient cofactors ...
 
Nutrition Beyond Calories & the Role Trees can play
Nutrition Beyond Calories & the Role Trees can playNutrition Beyond Calories & the Role Trees can play
Nutrition Beyond Calories & the Role Trees can play
 
Dr o'flaherty nutrient therapy as complementary treatment in psychiatry
Dr o'flaherty nutrient therapy as complementary treatment in psychiatryDr o'flaherty nutrient therapy as complementary treatment in psychiatry
Dr o'flaherty nutrient therapy as complementary treatment in psychiatry
 
Hepatoprotective agents
Hepatoprotective agentsHepatoprotective agents
Hepatoprotective agents
 
Epigenetics and it's relevance in crop improvement
Epigenetics and it's relevance in crop improvementEpigenetics and it's relevance in crop improvement
Epigenetics and it's relevance in crop improvement
 
Pharmacogenetics of antipsychotic and antidepressent
Pharmacogenetics of antipsychotic and antidepressentPharmacogenetics of antipsychotic and antidepressent
Pharmacogenetics of antipsychotic and antidepressent
 
Biology of ageing
Biology of ageingBiology of ageing
Biology of ageing
 
RECENT ADVANCES IN ALZHEIMER'S DISEASE
RECENT ADVANCES IN ALZHEIMER'S DISEASERECENT ADVANCES IN ALZHEIMER'S DISEASE
RECENT ADVANCES IN ALZHEIMER'S DISEASE
 
Gut microbiota
Gut microbiotaGut microbiota
Gut microbiota
 
Spirulina and human health
Spirulina and human healthSpirulina and human health
Spirulina and human health
 

More from Jennifer Spencer

The Limitations Inherent in using "benchmark" outcomes to estimate NHS health...
The Limitations Inherent in using "benchmark" outcomes to estimate NHS health...The Limitations Inherent in using "benchmark" outcomes to estimate NHS health...
The Limitations Inherent in using "benchmark" outcomes to estimate NHS health...Jennifer Spencer
 
Organisational Management Theory and the Patient Safety Movement: Not Enough ...
Organisational Management Theory and the Patient Safety Movement: Not Enough ...Organisational Management Theory and the Patient Safety Movement: Not Enough ...
Organisational Management Theory and the Patient Safety Movement: Not Enough ...Jennifer Spencer
 
Jennifer spencer Academic CV Draft 6 15 february2018
Jennifer spencer Academic CV Draft 6 15 february2018Jennifer spencer Academic CV Draft 6 15 february2018
Jennifer spencer Academic CV Draft 6 15 february2018Jennifer Spencer
 
CAMH Substantive Consultant Presentation for Cambridgeshire Post September 2014
CAMH Substantive Consultant Presentation for Cambridgeshire Post September 2014CAMH Substantive Consultant Presentation for Cambridgeshire Post September 2014
CAMH Substantive Consultant Presentation for Cambridgeshire Post September 2014Jennifer Spencer
 
Camh substantive consultant presentation for cambridgeshire post september 2014
Camh substantive consultant presentation for cambridgeshire post september 2014Camh substantive consultant presentation for cambridgeshire post september 2014
Camh substantive consultant presentation for cambridgeshire post september 2014Jennifer Spencer
 
LD RCPsych conf poster Draft 7 4Oct10
LD RCPsych conf poster Draft 7 4Oct10LD RCPsych conf poster Draft 7 4Oct10
LD RCPsych conf poster Draft 7 4Oct10Jennifer Spencer
 
Prodromal psychosis talk 25-11-09
Prodromal psychosis talk 25-11-09Prodromal psychosis talk 25-11-09
Prodromal psychosis talk 25-11-09Jennifer Spencer
 

More from Jennifer Spencer (7)

The Limitations Inherent in using "benchmark" outcomes to estimate NHS health...
The Limitations Inherent in using "benchmark" outcomes to estimate NHS health...The Limitations Inherent in using "benchmark" outcomes to estimate NHS health...
The Limitations Inherent in using "benchmark" outcomes to estimate NHS health...
 
Organisational Management Theory and the Patient Safety Movement: Not Enough ...
Organisational Management Theory and the Patient Safety Movement: Not Enough ...Organisational Management Theory and the Patient Safety Movement: Not Enough ...
Organisational Management Theory and the Patient Safety Movement: Not Enough ...
 
Jennifer spencer Academic CV Draft 6 15 february2018
Jennifer spencer Academic CV Draft 6 15 february2018Jennifer spencer Academic CV Draft 6 15 february2018
Jennifer spencer Academic CV Draft 6 15 february2018
 
CAMH Substantive Consultant Presentation for Cambridgeshire Post September 2014
CAMH Substantive Consultant Presentation for Cambridgeshire Post September 2014CAMH Substantive Consultant Presentation for Cambridgeshire Post September 2014
CAMH Substantive Consultant Presentation for Cambridgeshire Post September 2014
 
Camh substantive consultant presentation for cambridgeshire post september 2014
Camh substantive consultant presentation for cambridgeshire post september 2014Camh substantive consultant presentation for cambridgeshire post september 2014
Camh substantive consultant presentation for cambridgeshire post september 2014
 
LD RCPsych conf poster Draft 7 4Oct10
LD RCPsych conf poster Draft 7 4Oct10LD RCPsych conf poster Draft 7 4Oct10
LD RCPsych conf poster Draft 7 4Oct10
 
Prodromal psychosis talk 25-11-09
Prodromal psychosis talk 25-11-09Prodromal psychosis talk 25-11-09
Prodromal psychosis talk 25-11-09
 

Methylation & Epigenetics in Psychiatric Disorders

  • 1. EVALUATION & TREATMENT OF OVER- AND UNDER-METHYLATION IN THE PSYCHIATRIC POPULATION William J. Walsh, PhD Walsh Research Institute February 18, 2015 1
  • 2. Webinar Topics 1. Methylation 2. Epigenetics 3. Treatment of psychiatric patients who exhibit a methylation disorder. 2
  • 3. Walsh Research Institute Naperville, Illinois  501c3 Public Charity  Expertise in behavior disorders, ADHD, autism, depression, schizophrenia, bipolar disorder, and Alzheimer’s  International Physician-Training Program  Research 3
  • 4. Massive Chemistry Database  Laboratory testing of 30,000 mental health patients and controls.  More than 3 million chemical test results for patients diagnosed with schizophrenia, depression, ADHD, depression, autism, etc.  More than 2 million medical history factors for these populations. 4
  • 5. Database Findings Striking blood/urine chemistry differences between mental illness populations and the rest of society. Walsh WJ (2012). Nutrient Power. Skyhorse Publishing, New York, NY. Crayton JW, Walsh WJ (2007). J Trace Elements Med Biol.21:17-21. 5
  • 6. High-Incidence Imbalances in Mental Disorders Methylation Disorder Zinc Deficiency Copper Overload Folate Deficiency or Overload Pyrrole Disorder Toxic-Metal Overload EPA, DHA, and/or AA Deficiency These factors have a powerful impact on synthesis of neurotransmitters and regulation of NT activity. 6
  • 7. Methylation and Brain Disorders  Methylation status has been determined for 30,000 patients over a 30 year period,  Most persons diagnosed with mental disorders exhibit a serious methylation imbalance,  Accurate diagnosis of methylation status is essential to effective treatment. 7
  • 8. Recent Advances in Understanding of Brain Disorders Methylation Processes Epigenetics 8
  • 9. New Capability in Nutrient Therapy  Regulation of enzyme gene expression,  Control of serotonin & dopamine reuptake,  Improved antioxidant protection in the brain,  Promising treatments for addiction disorders. 9
  • 10. “I did then what I knew how to do. Now that I know better, I do better.” Maya Angelou 10
  • 11. 11
  • 12. 12
  • 13. 13
  • 14. 14
  • 15. 15
  • 16. 16
  • 17. 17
  • 18. 18
  • 19. 19
  • 20. 20
  • 21. 21
  • 22. 22
  • 23. 23
  • 24. 24
  • 25. 25
  • 26. 26
  • 27. 27
  • 28. Single Nucleotide Polymorphisms  We share 99.9% of our DNA with everyone of the same gender -- It’s the 0.1% that makes us different.  SNPs are gene mutations that developed over thousands of years.  More than 10 million SNPs have been identified in the human genome. Most humans have more than 1,000 SNPs. 28
  • 29. ENZYME SNPs  More likely in very-large enzymes,  Most SNPs have little or no effect on enzyme function,  Some strategically-placed SNPs significantly weaken enzyme function (MTHFR 677T, etc.),  Impact of a SNP varies from person to person. 29
  • 30. Size Matters  MTHFR – more than 500 amino acids, MW 77,000; 677T SNP present in >20% of all humans; 52% of all Italians.  Metallothionein – 61 amino acids – SNPs far less common but generally more harmful with respect to function. 30
  • 31. Methylation and Epigenetics  Methylation is a dominant factor in epigenetic processes,  SAMe, folates, niacin, and other nutrients have a powerful epigenetic impact on neurotransmitter activity at synapses,  More than 60% of ADHD, anxiety, depression and psychosis patients exhibit a serious methylation imbalance. 31
  • 32. Epigenetics  >20,000 genes in every cell’s DNA, each capable of producing a specific protein,  Liver, skin, brain, and other tissues require a unique combination of proteins,  During pregnancy, chemical “bookmarks” attach to DNA to enhance or inhibit gene expression in each tissue,  Environmental insults at any age can alter gene bookmarks and produce mental disorders and other disease conditions. 32
  • 33. Two Epigenetic Processes DNA Methylation Histone Modification 33
  • 34. DNA Methylation  Established in the womb,  Methylation of cytosine at promoter CpG island clusters can reduce expression (protein production) for the corresponding gene. These methyl “bookmarks” usually remain in place throughout a lifetime,  In-utero environmental insults can produce deviant bookmarks & serious disorders or birth defects,  Throughout life, a severe environmental insult may alter one or more gene-regulation marks and produce an epigenetic disorder such as cancer or a mental illness. 34
  • 36. Histones – Support Structures for the Fragile DNA  Composed of 8 linear proteins twisted together like a ball of yarn,  Originally believed to serve only as structural support for DNA packaging,  Later found to inhibit or promote gene expression depending on chemical reactions at histone tails.  Nutrient therapies can modify histones that control reuptake of serotonin, dopamine, and other NTs. 36
  • 37. 37
  • 38. 38
  • 39. Methyl-Acetyl Competition  Competition between acetyl and methyl groups often determines whether genes are expressed or silenced,  Acetyl bookmarks promote gene expression,  Methyl bookmarks inhibit expression,  Nutrient therapy can change methyl/acetyl ratios and adjust production of enzymes that control serotonin and dopamine neurotransmission rates. 39
  • 40. Gene Expression Requires Uncoiling of DNA  Gene expression involves direct interaction of RNA polymerase and transcription factors with DNA. These large molecules cannot gain access to DNA/histone regions that are densely compacted,  The gentle attachment of DNA to histones involves electrostatic attraction – DNA is a weak acid and histones are mild bases (pH above 7.0),  Acetylation decreases histone pH, causing uncoiling of DNA; methylation increases histone pH, increasing DNA/Histone compaction. 40
  • 41. 41
  • 42. 42
  • 43. Reuptake Transport Proteins  Primary determinant of neurotransmitter activity at serotonin & dopamine receptors – brain concentrations of serotonin and dopamine are less important,  Transmembrane proteins that remove neurotransmitters from the synapse (reuptake) like a vacuum cleaner inhaling dust particles,  Formed by gene expression: amount present depends on methyl/acetyl competition at specific DNA regions. 43
  • 44. Enzymes Dominate the Methyl-Acetyl Competition  Acetyl-Coenzyme A and SAMe are the donors of acetyl and methyl, respectively – but their concentrations in brain cells are relatively unimportant.  Acetylases, deacetylases, methylases and demethylases dominate attachment or removal of acetyl or methyl groups.  Epigenetic nutrient therapy for adjustment of serotonin or dopamine activity concentrates on the enzymes.  Example: B-3 inactivates a major deacetylase inhibitor, increasing expression of SERT, DAT transporters and reducing serotonin and dopamine neurotransmission. 44
  • 45. Epigenetic Insights Into Nutrient Therapy  Niacin & niacinamide act as dopamine reuptake promoters,  Methionine and SAMe are serotonin reuptake inhibitors,  Folates reduce synaptic activity at serotonin, dopamine, and norepinephrine receptors,  Zinc and glutathione increase glutamate activity at NMDA receptors,  Many nutrients influence neurotransmitter activity and brain function. 45
  • 46. Folates Reduce NT Activity  Folic Acid, folinic acid, and L-methylfolate are effective methylating agents.  However, folates also increase gene expression of SERT transport proteins, resulting in reduced serotonin neurotransmission.  Most undermethylated depressives with low- serotonin activity are intolerant to folates. 46
  • 47. Low Serotonin Activity Nutrient Therapy Approach  Enhance methylation and suppress acetylation of DNA and histones,  SAMe and methionine act as serotonin reuptake inhibitors – reduced gene expression of SERT,  Avoidance of folate supplements,  Augmenting nutrients – zinc, serine, inositol, TMG, Cal/Mag, Vitamins A, B-6, C, D, E. 47
  • 48. Treatment Example (160 lb adult) Undermethylated Depression  SAMe, 400 mg/day (reduce SERT expression and inhibit serotonin reuptake)  B-6, 200 mg/day and P5P, 50 mg/day (enhance synthesis of serotonin and glutathione) Antioxidant Support Vitamin C, 2000 mg/day Vitamin E, 400 mg/day Zinc (chelated form), 50 mg/day Selenium, 100 mcg/day Augmenting Nutrients as indicated Biotin, Ca, Mg, Cr, TMG, Inositol, Serine, Vitamins A, D 48
  • 49. Excessive Dopamine Activity Nutrient Therapy Approach  Support acetylation of histones with folic acid and niacinamide (powerful deacetylase inhibitors).  Augmenting nutrients DMAE, zinc, selenium, chromium, Vitamins B-6, B-12, C, D, E.  Especially promising for paranoid schizophrenics with excessive dopamine activity. 49
  • 50. Treatment Example (160 lb adult) Excessive Dopamine Activity  Folic Acid, 2400 mcg/day, and Niacinamide, 1000 mg/day to support acetylation of histones and promote reuptake of dopamine.  Augmenting nutrients DMAE, zinc, manganese, selenium, chromium, Vitamins B-6, B-12, C, D, E.  Especially promising for paranoid schizophrenics and anxiety/depression patients with excessive dopamine activity. 50
  • 51. The Power of Nutrients 1. Neurotransmitter synthesis 2. Epigenetic regulation of gene expression 3. Reuptake processes at synapses 4. Antioxidant protection 51
  • 52. Summary  Methylation imbalances play a critical role in most mental disorders,  Recent research in methylation and epigenetics is providing a roadmap for advanced nutrient therapies.  Nutrient therapy represents an effective weapon in the arsenal of a mental health practitioner. 52
  • 53. THANK YOU! William J. Walsh, PhD Walsh Research Institute www.walshinstitute.org 53
  • 54. Additional Information Sources Nutrient Power, Chapters 3-8 www.walshinstitute.org Physician Education Workshop Chicago Area ● May 27-30, 2015 Contact: sue@walshinstitute.org 54